FTD-TPI, Bevacizumab, and Radioembolization With 166Ho-microspheres in Refractory Metastatic Colorectal Cancer

Clinical trial NCT06563986 · RECRUITING

Trial details

NCT number: NCT06563986
Sponsor: UMC Utrecht
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2024-06-18
Primary completion: 2028-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.